Skip to main content
Clinical Trials

Modulation of Sorafenib induced autophagy using hydroxychloroquine in hepatocellular cancer (CTMS# 16-0076)

Cancer Type

Liver Identifier


Principal Investigator

Sukeshi Patel Arora MD

For more information about this study
View Details

About This Study

The PI is studying if sorafenib/hydroxychloroquine (HCQ) will have improved efficacy when compared to sorafenib alone and in patients progressing of sorafenib the addition of HCQ would lead to disease stability in patients with advanced hepatocellular cancer (HCC).